GlassScriptPhysician profile
Robert J Deutsch
NPI 1588674824
$1,484.40
in general payments reported to CMS, 2019-2025
18 companies · $243 in 2025
The $243 reported for 2025 was more than what 86% of Pediatric Emergency Medicine (Pediatrics) providers received nationally (typical 2025 total: $53.43).
See the full distribution for Pediatric Emergency Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2022: $156 · 2023: $380 · 2024: $521 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $414.19 | 2023-2024 | Veklury |
| Astrazeneca Pharmaceuticals LP | $175.08 | 2022-2023 | Andexxa |
| Abbvie INC. | $146.01 | 2023-2025 | Dalvance |
| Portola Pharmaceuticals, LLC | $137.59 | 2019 | |
| Chiesi USA, INC. | $123.14 | 2025 | Cleviprex |
| Shionogi INC | $109.65 | 2024 | Fetroja |
| Pharmacosmos Therapeutics INC. | $108.53 | 2024 | Monoferric |
| Janssen Pharmaceuticals, INC | $73.83 | 2019-2024 | Xarelto |
| Stryker Corporation | $24.63 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inari Medical, INC. | $23.80 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Csl Behring | $23.47 | 2023 | Kcentra |
| Aero US INC | $21.91 | 2025 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
| Molnlycke Health Care US, LLC | $20.74 | 2025 | Mepitel, Mepilex Ag, Mepilex Border Ag |
| Z-Medica, LLC | $18.65 | 2019 | |
| Bioxcel Therapeutics, INC. | $18.16 | 2023 | Igalmi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $15.60 | 2022 | |
| Rare Disease Therapeutics, INC. | $15.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.42 | 2024 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Deutsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.